Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BigBearai Holdings Inc (BBAI) vs Cytokinetics Inc (CYTK) Price & Performance

BigBearai Holdings IncTrade
Cytokinetics IncTrade

Price performance (Past 24H)

Key statistics

BigBearai Holdings Inc vs Cytokinetics Inc — how do they compare? BigBearai Holdings Inc trades at $3.32 (market cap $1.55B), while Cytokinetics Inc trades at $76.67 (market cap $10.78B). The key difference: Cytokinetics Inc is far larger — about 7× BigBearai Holdings Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, BigBearai Holdings Inc nearer its low. Which is the better fit depends on your goals.

BBAICYTK
Market Cap
$1.55B$10.78B
Sector
TechnologyTechnology
52-Week High
$8.91$87.26
52-Week Low
$2.61$34.31
Enterprise Value
$1.25B$10.88B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BigBearai Holdings Inc

BBAI trades at $3.27, up 8.64% with a bullish technical signal despite negative profitability metrics. The company reported Q2 2026 revenue growth of 13% and beat EPS estimates, though it remains unprofitable with a -65.2% net income margin. Recent news highlights defense contract execution and generative AI platform expansion for government clients.

The outlook remains challenging due to persistent losses and negative cash flow from operations, though analyst consensus leans neutral with 75% hold ratings. Key risks include execution on government contracts and achieving profitability, while technical indicators suggest near-term bullish momentum.

Cytokinetics Inc

Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.

The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.

Returns comparison

Trailing returns across standard periods

About BigBearai Holdings Inc

BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.

Read more on BBAI

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK